Clinical

Dataset Information

0

Artificial Intelligence System Based on Raman Spectroscopy in Inflammatory Bowel Disease


ABSTRACT: Inflammatory bowel diseases (IBD) are chronic inflammatory disorders that can be categorized as ulcerative colitis (UC), Crohn’s disease (CD) and indeterminate colitis (IC). Deep remission has been shown to improve disease outcome. There may be a lack of concordance between endoscopic and histologic remission. IBD patients with long standing colitis are at risk of developing dysplasia and colorectal cancer (CRC). However, it can be challenging to diagnose dysplasia in IBD patients during colonoscopy, as dysplasia frequently manifests as non-pedunculated lesions that present with only subtle visible changes or are even invisible due to the surrounding inflammation, scarring, pseudopolyps, or hyperplasia. Although white light endoscopy and chromoendoscopy are the current standard modality of imaging, there is still a gap to be bridged, in terms of improving endoscopic diagnosis of dysplasia and improving concordance of endoscopic and histologic remission. Raman spectroscopy is an inelastic light scattering technique provide specific fingerprints of molecular compositions and structures of biological tissues. It may be able to provide additional diagnostic information over standard endoscopy. A second-generation Raman endoscope system for improving in vivo tissue characterization and diagnosis during colonoscopy has been developed (SPECTRA IMDx system). Preliminary data suggested its utility in the diagnosis of colorectal neoplasia during colonoscopy. There is currently a lack of data concerning the application of this novel technology in the context of IBD. Specifically, whether the spectral signals generated can be used to better classify disease remission, and thus achieve higher concordance with histology when compared to standard endoscopy. It is also unclear whether this technology can be used to differentiate dysplastic mucosa from non-dysplastic mucosal in IBD patients. Hypotheses 1. Raman spectroscopy based artificial intelligence system has the potential to be used to differentiate disease remission from active mucosal inflammation and hence improve concordance between endoscopic and histologic remission, with the potential to decrease the need for random biopsies real-time during colonoscopy. 2. Raman spectroscopy based artificial intelligence system has the potential to differentiate dysplastic mucosa in IBD patients (low grade and high grade dysplasia; colorectal cancer) from non-dysplastic mucosa. real-time during colonoscopy.

DISEASE(S): Inflammatory Bowel Diseases,Intestinal Diseases

PROVIDER: 2377642 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2376206 | ecrin-mdr-crc
2022-09-16 | GSE186507 | GEO
2022-09-16 | GSE193677 | GEO
2012-04-20 | GSE37283 | GEO
2012-04-19 | E-GEOD-37283 | biostudies-arrayexpress
2020-09-16 | PXD018679 | Pride
2009-11-02 | E-GEOD-16879 | biostudies-arrayexpress
2012-11-09 | E-GEOD-38713 | biostudies-arrayexpress
2019-07-11 | E-MTAB-7854 | biostudies-arrayexpress
| PRJEB59025 | ENA